Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Merck KGaA, Darmstadt, Germany to Deploy Insilico Medicine’s Chemistry42 AI Platform for Generative Chemistry

Insilico Medicine announces the first deployment of its flagship generative chemistry AI platform for de novo molecular design, Chemistry42 on Merck KGaA, Darmstadt, Germany’s high-performance computing infrastructure

Following the release of Chemistry42 to a select group of key experts in the pharmaceutical industry in Q3 2020, Insilico Medicine is proud to announce that Merck KGaA, Darmstadt, Germany will be the first launch partner for its flagship generative chemistry artificial intelligence (AI) platform – Chemistry42. Merck KGaA, Darmstadt, Germany will integrate Chemistry42 into their discovery pipeline to facilitate rapid and effective drug design. Chemistry42 v1.0 will be customized and deployed on state-of-the-art high-performance computing (HPC) infrastructure at Merck KGaA, Darmstadt, Germany.

Since the publication of Ian Goodfellow’s original paper on generative adversarial networks (GANs) in 2014, Insilico Medicine has been developing generative chemistry and generative biology algorithms. In 2016, Insilico Medicine published the first peer-reviewed publication describing the application of GANs to small molecule discovery in oncology. Between 2016 and 2020 Insilico Medicine authored over 40 papers and has been granted several patents in this field. Insilico Medicine has conducted several proof of concept validation experiments that demonstrate that generative models can successfully identify novel targets, and design molecules with desired properties that can be synthesized and tested in vitro and in vivo.

Recommended AI News: TAAL Announces Agreement To Establish North American BitcoinSV Hosting Capacity To Support Large Scale Enterprise Clients

Chemistry42 is a core part of Insilico’s drug discovery suite. It is a flexible, user-friendly software platform that bridges artificial intelligence (AI) and machine learning methods with domain expertise in the fields of medicinal and computational chemistry, for the design of novel small molecules with desirable physicochemical properties. The platform is a scalable distributed web application, capable of running multiple tasks in parallel in a matter of hours. Container orchestration and workflow management allow for predictable hardware-agnostic resource allocation, and for the implementation on either cloud or local HPC infrastructures.

Related Posts
1 of 20,441

We are very happy to have Merck KGaA, Darmstadt, Germany sign on as our very first launch partner as they have substantial experience in the field of AI-powered drug discovery internally and built a world-class computing infrastructure,” said Alex Zhavoronkov, PhD, founder, and CEO, Insilico Medicine.

Recommended AI News: Morse Micro Announces An Additional $13 Million Funding Round To Accelerate Wi-Fi HaLow

“Chemistry42 v1.0 is the result of years of comprehensive research in generative chemistry, close collaboration between computational and medicinal chemistry scientists, and best high-performance computing engineering practices. We are excited to work closely with Merck KGaA, Darmstadt, Germany and look forward to demonstrating the impact of our collaboration on their drug discovery programs,” said Alex Zhebrak, PhD, CTO of Insilico Medicine.

“We’re excited to continue to deploy the latest tools in AI,” said Joern-Peter Halle, Global Head of Research for the Healthcare business sector of Merck KGaA, Darmstadt, Germany. “AI has the potential to transform the drug discovery process and Insilico Medicine is at the forefront of exciting AI techniques, such as this generative chemistry AI platform.”

Recommended AI News: XacBank Mongolia Selects Infosys Finacle To Power Its Digital Transformation

  1. a web hosting says

    I just couldn’t go away your website prior to suggesting that I extremely loved the standard info a person supply in your guests?
    Is going to be back continuously to inspect new

  2. says

    Fabulous, what a website it is! This web site presents valuable
    facts to us, keep it up.

  3. says

    I’ve been browsing on-line greater than three hours these days,
    yet I by no means found any attention-grabbing article like yours.

    It is pretty price enough for me. In my view, if all web
    owners and bloggers made excellent content as you did,
    the web might be a lot more helpful than ever before.

  4. a asmr says

    Thank you, I have recently been searching for information about
    this topic for a while and yours is the greatest I’ve found out till now.
    However, what in regards to the conclusion? Are you certain in regards to the supply?

  5. scoliosis surgery a says

    Hello there! I know this is kinda off topic nevertheless
    I’d figured I’d ask. Would you be interested in trading links or maybe
    guest authoring a blog article or vice-versa? My blog
    covers a lot of the same subjects as yours and I think we could greatly benefit from each
    other. If you happen to be interested feel free to shoot me an e-mail.
    I look forward to hearing from you! Terrific blog by the way!

  6. the asmr says

    This is very interesting, You are a very professional blogger.
    I have joined your feed and stay up for looking for extra of your excellent post.
    Additionally, I’ve shared your site in my social networks

  7. asmr their says

    Hi there, I want to subscribe for this web site to obtain latest updates, thus where can i do it please

  8. scoliosis surgery what says

    Valuable information. Fortunate me I found
    your site unintentionally, and I am shocked why this accident did not came about earlier!
    I bookmarked it.

  9. are asmr says

    Ahaa, its pleasant dialogue regarding this piece of writing at this place at this blog, I have read
    all that, so at this time me also commenting here.

  10. there quest bars says

    Fantastic site you have here but I was curious about if you knew of any community forums that cover the
    same topics talked about here? I’d really love to be a part of community where I can get
    advice from other experienced people that share the
    same interest. If you have any suggestions, please let me
    know. Bless you! quest bars quest bars

  11. says

    Good response in return of this query with firm arguments and explaining everything about that.
    cheap flights cheap flights

  12. says

    This article will help the internet people for creating new
    web site or even a weblog from start to end.
    scoliosis surgery scoliosis surgery

  13. says

    I like the valuable information you provide in your articles.
    I’ll bookmark your weblog and check again here regularly.
    I’m quite sure I’ll learn many new stuff right here!
    Good luck for the next! asmr asmr

  14. says

    I blog often and I genuinely thank you for your content.
    This great article has really peaked my interest. I’m going to
    take a note of your site and keep checking for new details about once per week.
    I opted in for your RSS feed too. scoliosis surgery scoliosis surgery

  15. 카지노사이트 says

    Think about it: What urge grabs the reader and compels him to write his comments? What gets him to talk about your post? What happens when the show’s over?
    We all tend to focus on catchy headlines and gripping titles. That split-second interest grabber is important. Copyblogger’s great posts on headlines thankfully tell you exactly how to craft your words to create snappy headlines.

  16. 카지노사이트 says

    How you end your post depends on what you’re trying to achieve and what action you want the reader to take. When it comes to prompting reader interaction, how you wrap up your blog posts or articles may make all the difference between a handful of comments and an explosion of discussion.
    Depending on how you’ve written your conclusion, there’s a good chance that nothing happens. The reader mentally nods and thinks, “Good post.” Then he or she moves on to something else.

  17. says

    Woah! I’m really digging the template/theme of this website.
    It’s simple, yet effective. A lot of times it’s hard to get
    that “perfect balance” between user friendliness and visual appeal.
    I must say you’ve done a great job with this. In addition, the blog loads extremely fast for me
    on Safari. Superb Blog! quest bars quest bars

Leave A Reply

Your email address will not be published.